Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TH1Z
|
||||
| Former ID |
DIB009415
|
||||
| Drug Name |
Naxagolide
|
||||
| Synonyms |
Dopazinol; Nazagolide; PHNO; Naxagolide hydrochloride; L-647339; MK-458; (+)-PHNO
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Discontinued in Phase 2 | [545272] | ||
| Company |
Merck & Co Inc
|
||||
| Formula |
C15H21NO2
|
||||
| Canonical SMILES |
[C@@H]12c3c(CC[C@H]1N(CCO2)CCC)ccc(c3)O
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Modulator | [533809] | |
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

